We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Topics Covered
- Pharmaceutical industry
- Artificial Intelligence
- Data integration
- Ontologies
- LLM
- Semantic search
- Vectors
- Knowledge graphs
- Generative AI
- Information provenance
Biography
Dr. Jane Lomax leads the ontologies team at SciBite, part of the Elsevier Group, in delivering scientific content and expert services. She has a PhD from Cambridge, and 20 years in biomedical ontologies, including EMBL-EBI and the Wellcome Sanger Institute. She has published over 50 papers, and regularly contributes to the OBO Foundry and ISB. Jane currently serves on the board at the Pistoia Alliance
Talk Citation
Lomax, J. (2025, March 10). AI and the pharma industry: what companies are, and could be, doing [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved July 3, 2025, from https://doi.org/10.69645/IESW1052.Export Citation (RIS)
Publication History
- Published on March 10, 2025
Financial Disclosures
- Dr. Jane Lomax has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Pharmaceutical Sciences
Transcript
Please wait while the transcript is being prepared...
0:00
Interviewer: Today I'm interviewing
Dr. Jane Lomax who heads
the Ontologies technical and
services team at SciBite,
part of the Elsevier
group of companies,
on the subject of what
pharma companies are
already doing and
could do to use AI
to better utilize the vast
amount of data they have
both to solve the
problem of knowing
what they already know
that is somewhere in
the organization in
some storage system,
database or silo and to
create new knowledge.
Dr. Lomax, thank you
for sparing the time.
May I structure this interview
by asking the following.
What do you see as the pharma
industry's perceived needs?
What tools do you have
to meet those needs?
How do you deploy those tools?
What can you currently achieve?
What do you expect to be
able to do in the near and
in the medium term future
that you can't currently do?
Finally, what do you
not see as possible
in the foreseeable future?
Dr. Lomax.
Dr. Lomax: Hi, Neil.
Thanks for having me on.
I think we start
at the start then.
What do you see as the pharma
industry's perceived needs?
I think the pharmaceutical
industry deals with data.
That is their wheelhouse.
Ultimately, they're making
medicinal compounds.
But really, what they're
dealing with is data.
There's a great quote from
Philippe Marc at Novartis.